Acadia Pharmaceuticals Inc. has announced that Scott Cenci has been appointed as Senior Vice President and Chief Information and Data Officer. In this role, Scott will be in charge of Acadia’s efforts to transform its operations using digital tools, data, and artificial intelligence. He will also be part of the company’s top leadership group and will report directly to the CEO, Catherine Owen Adams.
Health Technology Insights: Delta Development Closes Series A3, Leads Prehospital Blood
“We are excited to have Scott join Acadia,” said Catherine Owen Adams. “Scott has a strong background in digital transformation, AI innovation, and managing IT systems across major biopharmaceutical companies. His experience in expanding digital capabilities and creating business value will be very important as we continue to grow and change.”
Scott has over 25 years of experience in the pharmaceutical and biotech fields. He has held important leadership positions at companies like Genmab, Biogen, Zoetis, and Pfizer. Most recently, he was the Senior Vice President of Global Information Technology and Digital at Genmab, where he played a key role in turning IT into a full digital operation. This helped the company grow from 500 employees to over 2,700 and revenue from $750 million to more than $3 billion.
Health Technology Insights: OrbiMed Raises $1.86 Billion for Healthcare Royalty and Credit Fund V
Throughout his career, Scott has led large-scale digital and AI projects, implemented global ERP and cloud systems, and improved operations using agile methods and data analysis. He has also been involved in major corporate events such as IPOs, spin-offs, and mergers and acquisitions.
“I am honored to join Acadia at this important time,” said Scott Cenci. “It’s exciting to be part of a company that is strongly committed to using data, technology, and AI to speed up innovation and improve patient care. I look forward to working with the team to strengthen Acadia’s digital abilities and support its mission to bring new treatments to patients.” Scott has an MBA in Management Information Systems from Seton Hall University and a Bachelor of Science in Computer Science with a minor in Mathematics from The College of New Jersey. He has also advised industry groups and is a member of the Osage Venture Partners Technology Advisory Board. Scott often speaks about topics like Generative AI and digital transformation.
Health Technology Insights: EVERSANA Launches AI Life Sciences Agency on Google Cloud
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
